Dupilumab versus placebo in adults and adolescents with eosinophilic gastritis (DEGAS): a double-blind, placebo-controlled, phase 2, multicentre, randomised controlled trial.

Gonsalves NP, Dellon ES, Kliewer KL, Shoda T, Yearout R, Aceves SS, Arva NC, Besse JA, Caldwell JM, Chehade M, Coleman A, Collins MH, Anvari S, Falk GW, Gupta SK, Hiremath G, Katzka DA, Khoury P, Leung J, Menard-Katcher C, Menard-Katcher P, Peterson KA, Pletneva MA, Spergel AKR, Spergel JM, Vaysman T, Wechsler JB, Wright BL, Yang GY, Zhang X, Zhou M, Bansal A, Raphael BP, Radwan A, Maloney J, Martin A, Deniz Y, Furuta GT, Martin LJ, Rothenberg ME, Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR) Investigators

Open source

DOI
10.1016/s2468-1253(26)00116-0
Published
2026 Aug
Container
The lancet. Gastroenterology & hepatology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s2468-1253-26-00116-0,
  title = {Dupilumab versus placebo in adults and adolescents with eosinophilic gastritis (DEGAS): a double-blind, placebo-controlled, phase 2, multicentre, randomised controlled trial.},
  author = {Gonsalves NP and Dellon ES and Kliewer KL and Shoda T and Yearout R and Aceves SS and Arva NC and Besse JA and Caldwell JM and Chehade M and Coleman A and Collins MH and Anvari S and Falk GW and Gupta SK and Hiremath G and Katzka DA and Khoury P and Leung J and Menard-Katcher C and Menard-Katcher P and Peterson KA and Pletneva MA and Spergel AKR and Spergel JM and Vaysman T and Wechsler JB and Wright BL and Yang GY and Zhang X and Zhou M and Bansal A and Raphael BP and Radwan A and Maloney J and Martin A and Deniz Y and Furuta GT and Martin LJ and Rothenberg ME and Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR) Investigators},
  year = {2026},
  journal = {The lancet. Gastroenterology \& hepatology},
  doi = {10.1016/s2468-1253(26)00116-0},
  url = {https://doi.org/10.1016/s2468-1253(26)00116-0}
}

RIS

TY  - JOUR
TI  - Dupilumab versus placebo in adults and adolescents with eosinophilic gastritis (DEGAS): a double-blind, placebo-controlled, phase 2, multicentre, randomised controlled trial.
AU  - Gonsalves NP
AU  - Dellon ES
AU  - Kliewer KL
AU  - Shoda T
AU  - Yearout R
AU  - Aceves SS
AU  - Arva NC
AU  - Besse JA
AU  - Caldwell JM
AU  - Chehade M
AU  - Coleman A
AU  - Collins MH
AU  - Anvari S
AU  - Falk GW
AU  - Gupta SK
AU  - Hiremath G
AU  - Katzka DA
AU  - Khoury P
AU  - Leung J
AU  - Menard-Katcher C
AU  - Menard-Katcher P
AU  - Peterson KA
AU  - Pletneva MA
AU  - Spergel AKR
AU  - Spergel JM
AU  - Vaysman T
AU  - Wechsler JB
AU  - Wright BL
AU  - Yang GY
AU  - Zhang X
AU  - Zhou M
AU  - Bansal A
AU  - Raphael BP
AU  - Radwan A
AU  - Maloney J
AU  - Martin A
AU  - Deniz Y
AU  - Furuta GT
AU  - Martin LJ
AU  - Rothenberg ME
AU  - Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR) Investigators
PY  - 2026
JO  - The lancet. Gastroenterology & hepatology
DO  - 10.1016/s2468-1253(26)00116-0
UR  - https://doi.org/10.1016/s2468-1253(26)00116-0
ER  -

APA

NP, G., ES, D., KL, K., T, S., R, Y., SS, A., NC, A., JA, B., JM, C., M, C., A, C., MH, C., S, A., GW, F., SK, G., G, H., DA, K., P, K., J, L., C, M., P, M., KA, P., MA, P., AKR, S., JM, S., T, V., JB, W., BL, W., GY, Y., X, Z., M, Z., A, B., BP, R., A, R., J, M., A, M., Y, D., GT, F., LJ, M., ME, R., & Investigators, C. O. E. G. D. R. (. (2026). Dupilumab versus placebo in adults and adolescents with eosinophilic gastritis (DEGAS): a double-blind, placebo-controlled, phase 2, multicentre, randomised controlled trial.. The lancet. Gastroenterology & hepatology. https://doi.org/10.1016/s2468-1253(26)00116-0

Source records